reference/10901317

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10901317

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Intramural
endingPage	924
issn	1538-8514 1535-7163
issueIdentifier	5
pageRange	915-924
publicationName	Molecular Cancer Therapeutics
startingPage	915
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_969ccf6fe026f2f48265f62ea5c814c6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a929ac4e0e0fbe562a6c48e534a262a6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_812893f896624ca852391dd6173f4aec http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a17a13da33e78be7b43e202cc60bc193
bibliographicCitation	Schmidt KT, Chau CH, Strope JD, Huitema ADR, Sissung TM, Price DK, Figg WD. Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models. Mol Cancer Ther. 2021 May;20(5):915–24. PMID: 33632874; PMCID: PMC8102325.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1939-4639 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8ae84440603f66dbe628fe5edf89fb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6928-3833 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_434988dd9f44167d3a6822d40f680a46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0be8f56a86176ad030992711dd247a05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2428-5613 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d07150d350af10d793f0f68f87dfc81
date	2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/33632874 https://doi.org/10.1158/1535-7163.mct-20-0228 https://pubmed.ncbi.nlm.nih.gov/PMC8102325
isPartOf	https://portal.issn.org/resource/ISSN/1538-8514 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models
discusses	http://id.nlm.nih.gov/mesh/M0003242 http://id.nlm.nih.gov/mesh/M0577955 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0537664 http://id.nlm.nih.gov/mesh/M0016576 http://id.nlm.nih.gov/mesh/M0005463 http://id.nlm.nih.gov/mesh/M0014878
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003505Q000627 http://id.nlm.nih.gov/mesh/D064129Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D010669Q000627 http://id.nlm.nih.gov/mesh/D001549Q000627 http://id.nlm.nih.gov/mesh/D009570Q000627 http://id.nlm.nih.gov/mesh/D002166Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D009570Q000494 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D010669Q000494 http://id.nlm.nih.gov/mesh/D001549Q000494 http://id.nlm.nih.gov/mesh/D002166Q000494 http://id.nlm.nih.gov/mesh/D003505Q000494 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24360 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d4cb671d20806caaf5644afb03f6746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID184196 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951529

Total number of triples: 65.